Logo

Premier Biosoft Teams With MRC-Holland to Enhance MLPA Probes

Oct 25, 2006
NEW YORK (GenomeWeb News) — Premier Biosoft and MRC-Holland are partnering in a new venture that will couple Biosoft's software with the Dutch company's diagnostic tools, Biosoft said Monday.
 
To be known as Premier Biosoft International, the partnership will pool the companies' platforms and know-how to enable users of MRC-Holland's MLPA to design custom oligos for genes that do not already have kits available.
 
MLPA is used to establish the copy number of as many as 45 nucleic acid sequences in a single reaction, and is able to discriminate sequences differing by only one nucleotide.

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.